Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

2 results
12:00 AM, May 16, 2016  |  BC Week In Review | Company News  |  Other News

Epirus biosimilars, hematology, cancer news

preclinical compounds BOW080 , a biosimilar of Soliris eculizumab, to treat ultra-rare blood disorders and BOW070
12:00 AM, Aug 10, 2015  |  BC Week In Review | Company News  |  Deals

Epirus, Polpharma deal

Epirus partnered with Polpharma to develop and commercialize biosimilars BOW015 , BOW050 and BOW070 . BOW015 …
N.J.); BOW050 is a biosimilar of Humira adalimumab from AbbVie Inc. (NYSE:ABBV, Chicago, Ill.); and BOW070
retains U.S. rights to commercialize the biosimilar as well as rights to commercialize BOW050 and BOW070